| Literature DB >> 35387444 |
Olena Nemchyna1, Natalia Solowjowa1, Michael Dandel2, Yuriy Hrytsyna1, Julia Stein1, Jan Knierim1, Felix Schoenrath1,3, Felix Hennig1,3, Volkmar Falk1,3,4,5, Christoph Knosalla1,3,6.
Abstract
Objectives: Parameters of left ventricular (LV) mechanics, obtained from speckle-tracking echocardiography (STE), were found to be of prognostic value in patients with heart failure and those who underwent cardiac surgery. This study aimed to assess the value of STE in patients scheduled to undergo surgical ventricular restoration (SVR).Entities:
Keywords: heart failure; left ventricular aneurysm; outcome study; speckle-tracking echocardiography (STE); surgical ventricular repair; surgical ventricular restoration
Year: 2022 PMID: 35387444 PMCID: PMC8978793 DOI: 10.3389/fcvm.2022.824467
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Study flowchart.
Patient baseline characteristics and the univariate analysis for predicting the combined outcome.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Age, years (HR for 10 years) | 62 ± 11.5 | 1.3 | 1.1–1.6 | 0.015 |
| Female | 41 (26%) | 1.19 | 0.7–2.0 | 0.5 |
| BMI, kg/m2 | 28 ± 5 | 1.0 | 0.96–1.1 | 0.78 |
| Diabetes mellitus | 45 (28.5%) | 1.7 | 1.03–2.8 | 0.038 |
| Arterial hypertension | 108 (68.4%) | 1.58 | 9.9–2.7 | 0.1 |
| Atrial fibrillation | 18 (11.4%) | 3.35 | 1.8–6.4 | 0.0002 |
| Chronic kidney disease | 30 (19%) | 2.25 | 1.3–3.8 | 0.003 |
| Plasma creatinine, mg/dL (HR for 0.1 mg/dL) | 1.04[0.88; 1.3] | 2.3 | 1.3–3.8 | 0.003 |
| New York Hear Association (NYHA) functional class III–IV | 141 (89.2%) | 1.72 | 0.5–5.5 | 0.36 |
| Time since MI, years | 2.7 [0.3; 12.9] | 1.06 | 1.02–1.1 | 0.001 |
| Previous heart surgery | 11 (7%) | 2.03 | 0.9–4.5 | 0.08 |
| Intraoperative variables | ||||
| Endoventricular patch | 17 (10.8%) | 0.57 | 0.2–1.4 | 0.23 |
| Thrombectomy | 32 (20.3%) | 0.94 | 0.5–1.9 | 0.86 |
| CABG | 113 (71.5%) | 0.88 | 0.5–1.5 | 0.63 |
| Valve surgery | 44 (27.8%) | 1.72 | 1.1–2.8 | 0.03 |
| MV repair/replacement | 37 (23.4%) | 1.45 | 0.9–2.4 | 0.16 |
| AV replacement | 9 (5.7%) | 2.15 | 0.98–4.7 | 0.06 |
| Cross-clamp time, min | 78 ± 36 | 1.002 | 1.0–1.01 | 0.53 |
| Perfusion time, min | 136 ± 80 | 1.12 | 1.005–1.01 | 0.004 |
| Echocardiography | ||||
| LV shape type: | ||||
| LV EDDI, cm/m2 (HR for 10 cm/m2) | 3.1 [2.8; 3.4] | 1.64 | 1.1–2.5 | 0.027 |
| LV ESDI, cm/m2 (HR for 10 cm/m2) | 2.4 [1.9; 2.7] | 2.02 | 1.4–3.0 | 0.001 |
| LV EDVI, mL/m2 (HR for 10 mL/m2) | 104 [83; 134] | 1.05 | 0.99–1.1 | 0.09 |
| LV ESVI, mL/m2 (HR for 10 mL/m2) | 68 [52; 96] | 1.06 | 0.99–1.13 | 0.09 |
| SI (HR for 0.1) | 0.61[0.55; 0.67] | 1.66 | 1.2–2.6 | 0.001 |
| LV EF,% (HR for 5%) | 34 ± 9 | 0.89 | 0.77–1.01 | 0.07 |
| LV FS,% (HR for 5%) | 23 [15; 29] | 0.76 | 0.66–0.88 | 0.0002 |
| CI (Doppler), L/min/m2 | 1.84[1.48; 2.17] | 0.83 | 0.5–1.4 | 0.47 |
| WMSI | 1.9 [1.7; 2.2] | 1.6 | 0.79–3.1 | 0.2 |
| Basal WMSI | 1.33[1.0; 1.5] | 2.2 | 1.1–4.5 | 0.035 |
| LV mass index, g/m2 | 137[114; 163] | 1.005 | 1.0–1.01 | 0.09 |
| RVOTI, mm/m2 | 14.9[13.3; 16.4] | 1.03 | 0.95–1.1 | 0.5 |
| TAPSE, mm | 17.3 ± 4 | 0.97 | 0.9–1.03 | 0.28 |
| RV FAS, % | 38.7 ± 10 | 0.99 | 0.97–1.02 | 0.53 |
| Diastolic dysfunction grade | ||||
| 1 | 75 (57.3%)21 (16%)35 (26.7%) | – | – 0.7–3.1 0.99–3.2 | – |
| LAVI, mL/m2 (HR for 10 mL/m2) | 41 [34; 55] | 1.2 | 1.03–1.4 | 0.02 |
| MR 2+ | 45 (28.5%) | 1.62 | 0.99–2.7 | 0.055 |
| GLSp, % | −7.6[−9.7; −5.8] | 1.1 | 1.002–1.2 | 0.045 |
| GLSs, % | −5.4 [−7.7; −3.6] | 1.05 | 0.97–1.1 | 0.21 |
| GLSes, % | −5.2[−7.5; −3.3] | 1.07 | 0.98–1.16 | 0.12 |
| GLSR, s−1 | −0.53 [−0.64; −0.45] | 3.4 | 0.72–16.5 | 0.12 |
| BLSp, % | −11 ± 3.2 | 1.09 | 1.01–1.17 | 0.03 |
| BLSs, % | −9.9 ± 3.4 | 1.06 | 0.99–1.1 | 0.07 |
| BLSes, % | −9.3 ± 3.4 | 1.09 | 1.01–1.16 | 0.02 |
| BLSR, s−1 | −0.7[−0.8; −0.59] | 3.7 | 0.88–15.4 | 0.08 |
| Proportion of LV segments with PSS pattern, % | 41 [24; 53] | 1.0 | 0.98–1.0 | 0.29 |
| Proportion of LV basal segments with PSS pattern, % | 17 [17; 50] | 1.0 | 0.99–1.01 | 0.9 |
| MD, ms | 76 [58; 107] | 1.005 | 1.0–1.01 | 0.1 |
| Basal MD, ms | 69 [55; 81] | 1.01 | 1.0–1.02 | 0.003 |
AV, aortic valve; BLSp, peak basal longitudinal strain; BLSs, systolic basal longitudinal strain; BLSes, end-systolic basal longitudinal strain; BLSR, basal systolic longitudinal strain rate; BMI, body mass index; CABG, coronary artery bypass graft; CI, cardiac index; GLSp, peak global longitudinal strain; GLSs, systolic global longitudinal strain; GLSes, end-systolic global longitudinal strain; GLSR, global systolic longitudinal strain rate; E/A, early to late diastolic transmitral flow velocity; EDDI, end-diastolic diameter index; EDVI, end-diastolic volume index; EF, ejection fraction; ESDI, end-systolic diameter index; ESVI, end-systolic volume index; FS, fractional shortening; LAVI, left atrial volume index; LV, left ventricular; LVAD, left ventricular assist device; MD, mechanical dispersion; MI, myocardial infarction; MR, mitral regurgitation; MV, mitral valve; PSS, post-systolic shortening; RV FAS, right ventricular fractional area shortening; RVOTI, right ventricular outflow tract index; SI, sphericity index; TAPSE, tricuspid annular plane systolic excursion; WMSI, wall motion score index.
Data are presented as mean ± SD, median [interquartile range], n (%).
Proportion does not represent the total population (n = 131).
Echocardiographic parameters at the short-term follow-up after SVR.
|
|
|
|
|
|
|---|---|---|---|---|
| Heart rate, bpm | 43 | 72 ± 12 | 70 ± 10 | 0.35 |
| LV EDDI, mm/m2 | 43 | 3.0 | 2.9 | 0.08 |
| LV ESDI, mm/m2 | 43 | 2.5 | 2.2[1.8; 2.7] | 0.03 |
| LV EDVI, mL/m2 | 43 | 103 | 75 | <0.0001 |
| LV ESVI, mL/m2 | 43 | 67 | 45 | <0.0001 |
| LV EF, % | 43 | 33.1 ± 10 | 41.4 ± 11 | <0.0001 |
| LV FS, % | 43 | 21.6 ± 7.6 | 22 ± 8.8 | 0.72 |
| WMSI | 43 | 2.0 | 1.56[1.4; 1.8] | <0.0001 |
| Basal WMSI | 43 | 1.33 | 1.23[1.0; 1.5] | 0.44 |
| CI (Doppler), L/min/m2 | 25 | 1.66 | 2 | 0.19 |
| LAVI, mL/m2 | 38 | 43 | 42 | 0.03 |
| SI | 42 | 0.6 ± 0.1 | 0.69 ± 0.1 | <0.0001 |
| RVOTI, mm/m2 | 40 | 14.8 | 14.7[12; 16] | 0.33 |
| TAPSE, mm | 25 | 18 ± 4.6 | 13.7 ± 3.1 | 0.001 |
| RV FAS, % | 34 | 38.1 ± 12 | 38.1 ± 10 | 0.99 |
| Diastolic dysfunction grade | ||||
| 1 | 17 (39.5%) | 15 (34.9%) | ||
| MR 2+ | 40 | 14 (35 %) | 10 (25 %) | 0.34 |
|
| ||||
| GLSes, % | 27 | −5.7 ± 2.9 | −7.3 ± 3.8 | 0.012 |
| GLSR, s−1 | 27 | −0.56 ± 0.2 | −0.62 ± 0.2 | 0.06 |
| BLSes, % | 27 | −9.6 ± 3 | −9.7 ± 4 | 0.67 |
| BLSR, s−1 | 27 | −0.75 ± 0.2 | −0.79 ± 0.2 | 0.47 |
| Proportion of LV segments with PSS, % | 25 | 41 | 24[8; 41] | 0.045 |
| Proportion of basal segments with PSS, % | 25 | 33 | 24[8; 41] | 0.36 |
| MD, ms | 27 | 81 | 75[58; 91] | 0.39 |
| Basal MD | 27 | 69 | 62[53; 86] | 0.09 |
BLSp, peak basal longitudinal strain; BLSs, systolic basal longitudinal strain; BLSes, end-systolic basal longitudinal strain; BLSR, basal systolic longitudinal strain rate; CI, cardiac index; GLSp, peak global longitudinal strain; GLSs, systolic global longitudinal strain; GLSes, end-systolic global longitudinal strain; GLSR, global systolic longitudinal strain rate; E/A, early to late diastolic transmitral flow velocity; EDDI, end-diastolic diameter index; EDVI, end-diastolic volume index; EF, ejection fraction; ESDI, end-systolic diameter index; ESVI, end-systolic volume index; FS, fractional shortening; LAVI, left atrial volume index; LV, left ventricular; LVAD, left ventricular assist device; MD, mechanical dispersion; MR, mitral regurgitation; PSS, post-systolic shortening; RV FAS, right ventricular fractional area shortening; RVOTI, right ventricular outflow tract index; SI, sphericity index; SVI, stroke volume index; TAPSE, tricuspid annular plane systolic excursion; WMSI, wall motion score index.
Data are presented as mean ± SD, median (IQR) or n (%).
Figure 2Preoperative segmental longitudinal end-systolic strain of left ventricular (LV) basal segments with initial hypo- or akinesia according to the improvement in segmental wall motion at follow-up (A) and the receiver operating characteristic (ROC) curve for predicting an improvement in regional wall motion by preoperative strain (B).
Figure 3Echocardiography before surgical ventricular restoration (SVR) (left panel) and at the short-term follow-up (right panel) in a patient (65 years old, male) with end-systolic basal longitudinal strain (BLS) (-6.8%) and intermediate LV shape before SVR [without patch, no concomitant coronary artery bypass graft (CABG), or valve surgery]. At 12 months after SVR, there is a valuable improvement in EF (from 30 to 47%) and end-systolic global longitudinal strain (GLS) (from −6.8 to −13.1%), a decrease in LV end-diastolic volume (LVEDV) (from 226 to 124 ml) and LV end-systolic volume (LVESV) (from 159 to 66 ml) as well as decrease in mechanical dispersion (150 to 57 ms).
The multivariate analysis of preoperative echocardiographic parameters for predicting the combined outcome.
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| LV EDDI, 10 mm/m2 increase | 1.8 | 1.1–3.1 | 0.025 | 4.8 | 0.03 |
| LV ESDI, 10 mm/m2 increase | 2.2 | 1.3–3.7 | 0.003 | 8.8 | 0.003 |
| LV EDVI, 10 mL/m2 increase | 1.08 | 1.01–1.15 | 0.023 | 4.7 | 0.03 |
| LV ESVI, 10 mL/m2 increase | 1.1 | 1.02–1.18 | 0.02 | 5.0 | 0.025 |
| EF, 5 % increase | 0.81 | 0.7–0.96 | 0.014 | 6.1 | 0.013 |
| FS, 5 % increase | 0.77 | 0.6–0.9 | 0.005 | 8.5 | 0.004 |
| WMSI | 1.88 | 0.7–4.8 | 0.17 | 1.7 | 0.19 |
| Basal WMSI | 2.2 | 0.83–5.8 | 0.11 | 2.4 | 0.12 |
| LV shape | |||||
| Type 1 | – | – | – | 8.8 | 0.013 |
| SI, 0.1 increase | 1.4 | 1.1–1.8 | 0.014 | 5.7 | 0.02 |
| TAPSE | 0.99 | 0.93–1.1 | 0.84 | 0.04 | 0.84 |
| Diastolic dysfunction grade | |||||
| 1 | – | – | – | ||
| LAVI, 10 mL/m2 | 1.11 | 0.9–1.35 | 0.31 | 1 | 0.32 |
| MR 2+ | 1.3 | 0.7–2.5 | 0.34 | 0.9 | 0.35 |
| GLSs, % | 1.11 | 0.99–1.2 | 0.08 | 3.2 | 0.07 |
| GLSes, % | 1.12 | 1.01–1.28 | 0.046 | 4.1 | 0.04 |
| GLSp, % | 1.13 | 1.01–1.3 | 0.04 | 4.5 | 0.03 |
| GLSR, s−1 | 6.1 | 0.95–38.9 | 0.056 | 3.9 | 0.049 |
| BLSs, % | 1.11 | 1.02–1.22 | 0.017 | 5.7 | 0.017 |
| BLSes, % | 1.13 | 1.03–1.24 | 0.008 | 7.0 | 0.008 |
| BLSp, % | 1.14 | 1.03–1.25 | 0.01 | 6.7 | 0.01 |
| BLSR, s−1 | 7.2 | 1.35–38.7 | 0.021 | 5.8 | 0.016 |
| Proportion of segments with PSS | 1.0 | 1.0–1.02 | 0.83 | 0.05 | 0.83 |
| Proportion of basal segments with PSS | 1.0 | 1.0–1.01 | 0.92 | 0.01 | 0.92 |
| MD, 10 ms increase | 0.99 | 0.92–1.1 | 0.7 | 0.14 | 0.7 |
| Basal MD, 10 ms increase | 1.01 | 0.95–1.07 | 0.7 | 0.15 | 0.7 |
BLSp, peak basal longitudinal strain; BLSs, systolic basal longitudinal strain; BLSes, end-systolic basal longitudinal strain; BLSR, basal systolic longitudinal strain rate; CI, cardiac index; GLSp, peak global longitudinal strain; GLSs, systolic global longitudinal strain; GLSes, end-systolic global longitudinal strain; GLSR, global systolic longitudinal strain rate; E/A, early to late diastolic transmitral flow velocity; EDDI, end-diastolic diameter index; EDVI, end-diastolic volume index; EF, ejection fraction; ESDI, end-systolic diameter index; ESVI, end-systolic volume index; FS, fractional shortening; LAVI, left atrial volume index; LV, left ventricular; LVAD, left ventricular assist device; MD, mechanical dispersion; MR, mitral regurgitation; PSS, post-systolic shortening; SI, sphericity index; SVI, stroke volume index; TAPSE, tricuspid annular plane systolic excursion; WMSI, wall motion score index.
Figure 4Survival free from left ventricular assist device (LVAD) and heart transplantation according to BLS in the population as a whole (left panel) and in patients with an intermediate LV shape (right panel). The Kaplan-Meier survival curves are shown as a solid line with ticks indicating censor points; shadings represent 95% CI.